当前位置:首页 - 行情中心 - 安旭生物(688075) - 财务分析 - 现金流量表

安旭生物

(688075)

  

流通市值:49.28亿  总市值:49.28亿
流通股本:1.27亿   总股本:1.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金339,734,120.67255,767,375.25103,961,347.43529,593,010.82
  收到的税费返还32,717,313.7619,923,566.088,704,418.8761,271,458.05
  收到其他与经营活动有关的现金44,642,619.2919,199,858.2814,855,431.9131,612,013.89
  经营活动现金流入小计417,094,053.72294,890,799.61127,521,198.21622,476,482.76
  购买商品、接受劳务支付的现金201,488,386.32156,274,963.4366,941,915.16324,711,771.82
  支付给职工以及为职工支付的现金112,547,131.1578,669,055.442,298,975.77108,223,493.18
  支付的各项税费53,857,043.9727,374,879.9617,711,780.2121,591,452.07
  支付其他与经营活动有关的现金48,019,054.2629,053,349.2911,667,309.0892,856,538.42
  经营活动现金流出小计415,911,615.7291,372,248.08138,619,980.22547,383,255.49
  经营活动产生的现金流量净额1,182,438.023,518,551.53-11,098,782.0175,093,227.27
二、投资活动产生的现金流量:
  收回投资收到的现金8,804,098,122.995,718,959,380.452,957,353,620.097,722,545,500
  取得投资收益收到的现金21,670,686.0321,585,014.816,492,703.74143,369,469.63
  处置固定资产、无形资产和其他长期资产收回的现金净额---7,795,364.81
  收到的其他与投资活动有关的现金---20,010,312.43
  投资活动现金流入小计8,825,768,809.025,740,544,395.252,973,846,323.837,893,720,646.87
  购建固定资产、无形资产和其他长期资产支付的现金54,144,956.1136,787,63316,950,520107,112,789.44
  投资支付的现金8,942,858,961.915,947,194,765.332,977,598,786.047,619,776,616.66
  支付其他与投资活动有关的现金362,910-358,910-
  投资活动现金流出小计8,997,366,828.025,983,982,398.332,994,908,216.047,726,889,406.1
  投资活动产生的现金流量净额-171,598,019-243,438,003.08-21,061,892.21166,831,240.77
三、筹资活动产生的现金流量:
  偿还债务支付的现金---2,720,000
  分配股利、利润或偿付利息支付的现金106,474,954.59--101,696,048.78
  支付其他与筹资活动有关的现金---5,311,877.37
  筹资活动现金流出平衡项目0--0
  筹资活动现金流出小计106,474,954.59--109,727,926.15
  筹资活动产生的现金流量净额平衡项目0--0
  筹资活动产生的现金流量净额-106,474,954.59---109,727,926.15
四、汇率变动对现金及现金等价物的影响349,671.9684,577.43328,899.8718,110,297.51
五、现金及现金等价物净增加额-276,540,863.67-239,234,874.12-31,831,774.35150,306,839.4
  加:期初现金及现金等价物余额458,283,678.15458,283,678.15458,283,678.15307,976,838.75
  期末现金及现金等价物余额181,742,814.48219,048,804.03426,451,903.8458,283,678.15
补充资料:
  净利润-59,184,712.24-192,236,967.64
  资产减值准备---12,777,723.36
  固定资产和投资性房地产折旧-23,156,710.62-44,319,063.77
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,156,710.62-44,319,063.77
  无形资产摊销-2,271,400.74-3,949,125.3
  长期待摊费用摊销-3,081,562.54-5,928,928.1
  处置固定资产、无形资产和其他长期资产的损失--131,398.95--4,610,768.06
  固定资产报废损失----144,995.35
  公允价值变动损失--22,444,815.69--63,426,961.5
  财务费用-9,857,347.94--13,736,801.1
  投资损失--59,702,962.11--118,212,228.95
  递延所得税-691,825.62-5,638,747.14
  其中:递延所得税资产减少--1,645,731.09-3,291,531.26
    递延所得税负债增加-2,337,556.71-2,347,215.88
  存货的减少-11,535,381.68-42,186,757.96
  经营性应收项目的减少-9,151,444.76-12,010,329
  经营性应付项目的增加--33,396,636.02--60,760,599.24
  现金的期末余额-219,048,804.03-458,283,678.15
  减:现金的期初余额-458,283,678.15-307,976,838.75
  现金及现金等价物的净增加额--239,234,874.12-150,306,839.4
公告日期2025-10-312025-08-202025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑